The pharma giant raised the U.S. price of about two dozen drugs Jan. 10, including its psoriasis treatment Stelara and blood thinner Xarelto, Reuters reports.
Most increases ranged from 6 percent to 7 percent.
J&J said it does not plan to raise prices on any more drugs this year.
Drugmakers kicked off 2019 by raising the prices of more than 250 medications. That total has now almost doubled, with drugmakers hiking prices on nearly 490 drugs by Jan. 10.
Read the full report here.
More articles on pharmacy:
Hospital-owned drug company attracts 12 more health systems
How nurses are becoming integral to pharma marketing: 7 notes
4 tips for managing drug spend from Alameda Health System’s Dr. Yi-Chih Peng
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
